Hikma announces exclusive commercial partnership with Emergent BioSolutions for KLOXXADO® (naloxone HCl) nasal spray 8 mg
Hikma Pharmaceuticals PLC (Hikma), the multinational pharmaceutical group, today announces that it has entered an exclusive commercial partnership with Emergent BioSolutions (Emergent) for the sale of KLOXXADO® naloxone HCl nasal spray 8 mg in the U.
ABC News (AU) on MSN6h
Illegal tanning nasal spray not a 'harmless alternative' to sunbaking, says TGAExperts are warning against the nasal tanning spray, which is marketed to young people as a quick way to get a lasting tan.
MLive- Flint/Saginaw/Bay City on MSN13h
SVSU, Delta College get Narcan ‘rescue boxes’ to combat opioid crisisThe first two boxes are in honor of the late Nicholas P. “Nick” Kastros, a recovery advocate and AmeriCorps VISTA member at ...
Amid opioid overdoses and deaths, the Fall River School Committee voted to teach high school students how to give people ...
Preliminary fourth quarter neffy® net product revenue of approximately $6.5 million Preliminary cash, cash equivalents and ...
BioSolutions' strategic turnaround plan and cost-cutting efforts are paving the way for profitability in 2025. Explore more ...
An experience with over-the-counter nasal spray showed Hilary Koch how drug manufacturers often rely on sins of omission.
Dr. Scott Manthei of the Nevada Ear and Sinus Institute has been advising patients against taking drugs like Sudafed for ...
Vistagen has reported positive outcomes from the exploratory Phase IIA trial of an investigational pherine nasal spray, PH284 ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback